Latka logo
Medtep logo

Medtep

Barcelona, Spain

2023 Revenue

$243.9K(Est.)

Team

11

Founded

2011

Medtep Revenue (2023)

Medtep generated an estimated $243.9K in annual revenue in 2023. Source: GetLatka estimate

Provider of personalized medicine. The company's products uClinics and uPatient aggregate and merge any kind of data (from apps, devices, sensors and the likes), so the needed information can be given to any patient through a healthcare professional. It focus on disease prevention through monitoring of people's life habits.

Last updated

Medtep Revenue

In 2023, Medtep's revenue reached $243.9K. The company previously reported $203.2K in 2021.

Medtep Revenue GrowthReported revenue / ARR over time · latest figure estimated$0$60K$120K$180K$240K$300K2011201320152017201920212023$0$203.2K$243.9KSource: GetLatka.com
YearMilestoneSource
2023Medtep Hit $243.9k revenue in October 2023Estimated
2021Medtep Hit $203.2k revenue in April 2021Not recorded
2011Launched with $0 revenue

Founder / CEO

Medtep Employees & Team Size

Medtep employs approximately 11 people as of 2026.

Medtep Team GrowthReported headcount over time035810132011201320152017201920212023001111Source: GetLatka.com
YearMilestoneSource
2023Reached 11 employees (October 2023)Not recorded
2022Reached 11 employees (October 2022)Not recorded
2021Reached 11 employees (December 2021)Not recorded
2021Reached 4 employees (April 2021)Not recorded

Frequently Asked Questions about Medtep

Is Medtep still operating?

No. Medtep has shut down.

What is Medtep's revenue?

As of 2023, Medtep generated an estimated $243.9K in annual revenue.

Who founded Medtep?

Medtep was founded by Pablo Pantaleoni.

When was Medtep founded?

Medtep was founded in 2011.

How many employees does Medtep have?

As of 2023, Medtep had 11 employees.

Where is Medtep headquartered?

Medtep is headquartered in Barcelona, Spain.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile